#FutureReadyHealthcare
Emerging Biotech
Develop and commercialize your product with an experienced partner
Emerging biotech innovators are constrained by
Capital
as commercialization costs typically require $50-100 million every year
Autonomy
as large company partnerships often yield strategic brand control
Deal structures
with pharma companies result in forfeiture of majority revenue stream
What we do
From clinical development through launch to LOE (Loss of Exclusivity), our medical and commercial experts bring institutional knowledge of therapeutic areas and leverage technology to deliver meaningful outcomes at each step of the development to commercialization value chain. Our technology-led Centers of Excellence (COEs) are flexible to scale up or down quickly to align with your pace of growth.
Having developed capabilities organically over the last 20+ years and integrated new partners thoughtfully, we provide a cohesive experience across the product lifecycle. We seamlessly manage the complex and interdependent pharma model, from clinical, medical and commercial operations with a purpose-built model that is unified at its core. That’s why we built capabilities across the development to commercialization value chain.
